Luxa Biotechnology Revenue and Competitors
Estimated Revenue & Valuation
- Luxa Biotechnology's estimated annual revenue is currently $1.4M per year.
- Luxa Biotechnology's estimated revenue per employee is $201,000
Employee Data
- Luxa Biotechnology has 7 Employees.
- Luxa Biotechnology grew their employee count by 40% last year.
Luxa Biotechnology's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Clinical Project Manager for Luxa Biotechnology LLC with the Neural Stem Cell Institute | Reveal Email/Phone |
Luxa Biotechnology Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $53.7M | 267 | 16% | N/A | N/A |
#2 | $53.1M | 264 | 21% | N/A | N/A |
#3 | $69.1M | 344 | 26% | N/A | N/A |
#4 | $22.1M | 110 | -10% | N/A | N/A |
#5 | $151.8M | 755 | 11% | N/A | N/A |
#6 | $63.9M | 318 | 13% | N/A | N/A |
#7 | $29.9M | 149 | 13% | N/A | N/A |
#8 | $1.7M | 17 | -6% | $114.3M | N/A |
#9 | $6.8M | 34 | -6% | N/A | N/A |
#10 | $12.5M | 62 | -9% | N/A | N/A |
What Is Luxa Biotechnology?
Luxa Biotechnology (LuxaBio) is a clinical-stage biotechnology company developing a novel adult RPE stem cell (RPESC) therapy for dry AMD. The proprietary adult RPESC-derived RPE stem cell product was developed at and licensed from the NSCI. LuxaBio is a partnership between the NSCI research institute and Y2 Solution, a Korean company to evaluate RPESC in a clinical trial to test the safety and efficacy of RPE progenitor stage progeny as a potential therapy for dry AMD. \n\nLuxaBio maintains a robust research program at NSCI to develop the RPESC as an effective, commercially viable cell product. The Phase 1/2a clinical trial of RPESC-RPE-4W for the Treatment of Dry Age-related Macular Degeneration includes the Cedars Sinai Biomanufacturing Center, Emmes, the University of Michigan Kellogg Eye Center, the National Eye Institute.
keywords:N/AN/A
Total Funding
7
Number of Employees
$1.4M
Revenue (est)
40%
Employee Growth %
N/A
Valuation
N/A
Accelerator
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $0.1M | 7 | 0% | $6.1M |
#2 | $3.5M | 7 | -30% | N/A |
#3 | $0.5M | 7 | N/A | N/A |
#4 | $0.9M | 7 | N/A | N/A |
#5 | $0.5M | 7 | N/A | N/A |
